Diversion-p64: results from an international, prospective, multicenter, single-arm post-market study to assess the safety and effectiveness of the p64 flow modulation device.
Alain BonafeMarta Aguilar PerezHans HenkesPedro LylykCarlos BleiseGregory GascouStanimir S SirakovAlexander SirakovLuc StockxFrancis TurjmanAndrey PetrovChristian RothAna-Paula NarataXavier BarreauChristian LoehrAnsgar BerlisSébastien SoizeMarcin MiśA J P GoddardAndy CliftonJoachim KlischCezary WałęsaMassimo Dall'OlioLaurent SpelleFrédéric ClarenconSergey YakovlevPeter KestonNunzio Paolo NuzziStefanita DimaChristina WendlTine WillemsPeter SchrammPublished in: Journal of neurointerventional surgery (2021)
Diversion-p64 is the largest prospective study using the p64 flow modulation device. The results of this study demonstrate that the device has a high efficacy and carries a low rate of mortality and permanent morbidity.